These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4. Mak A, Uetrecht J. Chem Res Toxicol; 2015 Aug 17; 28(8):1567-73. PubMed ID: 26154582 [Abstract] [Full Text] [Related]
8. The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury. Mak A, Cho TE, Uetrecht J. Chem Res Toxicol; 2018 Aug 20; 31(8):739-744. PubMed ID: 29938495 [Abstract] [Full Text] [Related]
9. Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury. Mak A, Cho T, Uetrecht J. J Immunotoxicol; 2018 Dec 20; 15(1):90-95. PubMed ID: 29733743 [Abstract] [Full Text] [Related]
14. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation. Shibolet O, Alper R, Zolotarov L, Trop S, Thalenfeld B, Engelhardt D, Rabbani E, Ilan Y. Clin Immunol; 2004 Apr 20; 111(1):82-92. PubMed ID: 15093555 [Abstract] [Full Text] [Related]
18. The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury. Mak A, Uetrecht J. Chem Res Toxicol; 2015 Dec 21; 28(12):2287-91. PubMed ID: 26529122 [Abstract] [Full Text] [Related]